SCHEMBL31240495

SCHEMBL31240495

Nc1n[nH]c2ccc(-c3ccnc4[nH]c(-c5cccc(C(=O)O)c5)cc34)cc12

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CLK2 P49760 9/20 0.53
▸ DYRK1A Q13627 9/20 0.53
▸ CLK3 P49761 8/20 0.53
▸ CHUK O15111 3/20 0.48
▸ INSR P06213 3/20 0.48
▸ MAPK8 P45983 3/20 0.48
▸ CAMKK2 Q96RR4 3/20 0.48
▸ MAPK1 P28482 1/20 0.45
▸ MAP2K4 P45985 1/20 0.45
▸ MAPKAPK3 Q16644 1/20 0.45
▸ MAPK6 Q16659 1/20 0.45
▸ JAK2 O60674 1/20 0.44
▸ PRKCI P41743 1/20 0.44
▸ TBK1 Q9UHD2 1/20 0.44
▸ AXL P30530 1/20 0.43
▸ CCNT1 O60563 1/20 0.43
▸ CDK9 P50750 1/20 0.43
▸ EGFR P00533 1/20 0.43
▸ WNT1 P04628 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240437 0.92 MAPK8 (0.55) CLK2DYRK1ACLK3CHUKINSR
SCHEMBL31240405 0.86 CLK2 (0.59) CLK2DYRK1ACLK3JAK2EGFR
SCHEMBL31240700 0.86 CLK2 (0.58) CLK2DYRK1ACLK3JAK2TBK1
SCHEMBL31240705 0.86 CLK2 (0.57) CLK2DYRK1ACLK3CHUKINSR
SCHEMBL31240587 0.86 CLK2 (0.56) CLK2DYRK1ACLK3JAK2CCNT1
SCHEMBL31240434 0.84 CHUK (0.57) CLK2DYRK1ACLK3CHUKINSR
SCHEMBL31240414 0.84 CCNT1 (0.49) CLK2DYRK1ACLK3CHUKINSR
SCHEMBL31240550 0.82 DYRK1A (0.51) CLK2DYRK1ACLK3CHUKINSR
SCHEMBL31240306 0.81 DYRK1A (0.71) CLK2DYRK1ACLK3TBK1WNT1
SCHEMBL31240425 0.81 NUDT1 (0.48) CLK2DYRK1ACLK3JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback